Navigation Links
Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Date:3/1/2010

harma.com.  Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through March 22, 2010.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C.  The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature consti
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 CorMedix Inc. ("CorMedix") ... developing and commercializing therapeutic products for the prevention ... announces the amendment and restatement of its outstanding ... and related warrants, as well as the warrants ... warrant financing, to remove anti-dilution, price reset and ...
(Date:9/16/2014)... , Sept. 16, 2014 Imprimis Pharmaceuticals, ... company dedicated to delivering high quality and novel medicines ... that Chief Executive Officer Mark Baum will ... Craig-Hallum Alpha Select Conference in New York City.  Mr. ... Go Dropless™ campaign in ophthalmology. The presentation is ...
(Date:9/16/2014)... Sept. 16, 2014  Wearable sports and activity ... less than two years, producing a massive amount ... huge opportunity exists for leveraging this data to ... ) introduced a first-of-its-kind wearable analytics platform for ... of clinical research linking activity and health risks, ...
Breaking Medicine Technology:CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3
... Qualcomm Incorporated (NASDAQ: QCOM ), as ... Centers for Disease Control and Prevention (KCDC), and Korea ... of Understanding for a project that will benefit patients ... Quality Care , which will utilize 3G-enabled applications and ...
... Experts in Telehealth(SM), received one of six national ... Affairs for Home Telehealth Devices and Services.  Cardiocom ... services portfolio which includes its Commander Home Telehealth ... Patient Management Software.   "We are ...
Cached Medicine Technology:Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 2Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 3Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 4Cardiocom Receives U.S. Department of Veteran Affairs National Contract for Home Telehealth Devices 2
(Date:9/16/2014)... make discoveries everyday, but that doesn,t mean the findings ... for example, the neonatal mortality rate is 10 times ... found that applying an inexpensive topical solution of chlorhexidine ... mortality rate by 24 percent, many Indian parents did ... is not that we don,t have solutions to solve ...
(Date:9/16/2014)... WASHINGTON D.C., September 16, 2014 A team of ... Medicine has developed a new model to study the ... determine how these motions relate to communication within a ... Escherichia coli bacteria to a microcantilever ... a diving board thus coupling its motion to ...
(Date:9/16/2014)... prospective study that compared patient-reported outcomes of a ... demonstrates that single fraction radiation therapy (SFRT) is ... (MFRT) when pain, function and quality of life ... the American Society for Radiation Oncology,s (ASTRO,s) 56th ... in patients, pain, function and degree of distress ...
(Date:9/16/2014)... Beginning October 1st 2014, Dallas’ Park ... for its clients who book a recurring visit schedule, and ... they buy. Most recurring visit clients are ones that ... but others include clients whose unique work schedules or lifestyles ... a daily basis. The newly introduced 15-minute visit length ...
(Date:9/16/2014)... Founded by former Miami Beach mayoral ... political organization fighting to legalize medical marijuana in Florida. ... After Party recently commissioned a shot-for-shot parody video of ... the movie “Grease.” ( http://youtu.be/zdcvhUgeDRg ) , Called “You’re ... musical parody faithfully recreates the carnival scene made famous ...
Breaking Medicine News(10 mins):Health News:Pairing social networks with social motives to close the science gap 2Health News:Pairing social networks with social motives to close the science gap 3Health News:And so they beat on, flagella against the cantilever 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 2Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 3Health News:Miami Beach Politician Drives 1,400 Miles to Texas to Shoot “Grease” Parody Video Supporting the Legalization of Medical Marijuana in Florida 2
... Technology Integrated with the Award Winning ... CytoViva ... Inc., a leading provider,of optical imaging solutions to the ... with its advanced,nano- scale microscope system. This combination of ...
... Aug. 21 Hospira, Inc.,(NYSE: HSP ... delivery,company, today announced new national agreements with ... Premier,s 2,000 member,hospitals with access to special ... general-purpose medication infusion devices, related,sets and disposables, ...
... Democratic National,Convention, WASHINGTON, Aug. 21 RCRC ... hold two events at the Democratic,National Convention to ... campaign. RCRC,s president, The Reverend Dr. Carlton W.,Veazey, ... available for media,interviews. RCRC is the national coalition ...
... Press Club (Zenger room), WASHINGTON, Aug. 21 ... Club:, Grace-Marie Turner, CEO Galen Institute - ... debate over free-market ideas of,health reform, Melinna ... founder of a,coding system and billing platform that ...
... commitment to industry best practices, meets new ... ... health care consulting,practice Halleland Health Consulting announces the development ... benefit managers (PBMs) seeking the level of excellence required,by ...
... FRANCISCO, Aug. 21 Bruce Bodaken,Chairman, President & CEO ... on the 2008 Rocky Mountain Roundtable on Health, Wellness ... on Monday,August 25, 2008, 9:30 a.m. MDT at Boettcher ... discuss the importance of wellness programs,in health reform, and ...
Cached Medicine News:Health News:CytoViva(R) Introduces Breakthrough Nano-Technology Research Tool 2Health News:Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment 2Health News:Halleland Health Consulting Establishes URAC Accreditation Program 2Health News:Blue Shield of California CEO to Speak at Democratic Convention Host Committee's Health Roundtable in Denver 2
... ability to fuse multiple image sets in ... for treatment planning and follow-up. ImageFusion aligns ... complementary features of different scan types. Radionics ... so clinicians can capitalize on the unique ...
... Framelink Stereotactic Linking System simplifies planning for ... (DBS). This software integrates multiple patient ... recording data, to assist in charting the ... target location. Framelink interfaces seamlessly with ...
It provides cranial support in either supine or semi-sitting procedures....
Mathews hand drill, with knurled shank and rotating head....
Medicine Products: